Free tool
Diagnostics stocks
We cover 11 companies grouped under the Diagnostics theme. The median market value in the group is $1.02B. Across the group, the median move over the past trading day is +0.26%. Price change over the past year runs from −30.5% to +117.4% across the middle 80 percent of the group, with a median of +23.3%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
11 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.24% |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +23.25% |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.70% |
| CAI | Caris Life Sciences, Inc. | $7.38B | Mid cap | −27.21% |
| CDNA | CareDx, Inc. | $2.63B | Mid cap | +298.43% |
| CSTL | Castle Biosciences, Inc. | $1.02B | Small cap | +70.15% |
| YDES | YD Bio Ltd | $331.49M | Small cap | −64.97% |
| XGN | Exagen Inc. | $184.11M | Small cap | −22.84% |
| PRPO | Precipio, Inc. | $55.23M | Micro cap | +117.41% |
| RIBB | Ribbon Acquisition Corp. | $54.52M | Micro cap | +6.62% |
| BIAF | bioAffinity Technologies, Inc. | $3.14M | Micro cap | −30.52% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.